Table 1

Side effects induced by various cholinergic agonists

CompoundFrequency Observed 10 min after DrugPeak Hypothermia
CHROMOLACRISALIVTREMΔ TemperatureAfter DrugHypothermia Duration
mg/kg i.p. % °C min
Oxotremorine
 0.3 (n = 10)010401-150 20−1.111-160 2010–601-a
 1.0 (n = 10)901-150 901-150 901-150 801-150 −1.421-160 2010–601-a
 3.0 (n = 10)501-150 701-150 701-150 801-150 −1.411-160 601-a 20–601-a
Pilocarpine
 3.0 (n = 8)12.52500−0.801-160 3010–60
 10 (n = 8)87.51-150 87.51-150 62.51-150 0−1.651-160 3010–901-a
 30 (n = 8)1001-150 1001-150 1001-150 0−1.901-160 901-a 30–901-a
Arecoline
 3.0 (n = 8)0012.50−1.151-160 1010–30
 10 (n = 8)001001-150 0−1.401-160 1010–30
 30 (n = 8)062.51-150 1001-150 37.5−1.491-160 1010–30
WAY-132983
 3.0 (n = 8)0012.50−1.221-150 3010–60
 10 (n = 8)0062.51-150 0−2.051-160 6010–120
 30 (n = 8)001001-150 12.5−1.491-160 12030–120
Xanomeline
 0.3 (n = 8)0000−0.1130
 3.0 (n= 8)0000−0.4010
 10 (n= 7)00751-150 0−0.581-160 3010–30
 30 (n = 8)0087.51-150 0−2.031-160 3010–901-a
mg/kg p.o.
WAY-132983
 3.0 (n = 8)12.512.5250−0.671-160 3030
 10 (n = 8)00501-150 0−1.021-160 6030–60
 30 (n = 8)12.512.587.51-150 0−1.521-160 12030–120
Xanomeline
 3.0 (n = 8)0000+0.1510
 10 (n = 8)00501-150 0−0.07601-a
 30 (n = 8)0037.50−0.1110
  • 1-a Last time point tested.

  • 1-150P < .05 versus vehicle (Fisher's).

  • 1-160P < .05 versus vehicle (LSD).